UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number 001-13341 Titan Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) Delaware 94-3171940 (State or other j ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-13341 TITAN PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 94-3171940 (State or other jurisd ...

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) Q2 2020 Earnings Conference Call August 14, 2020 1:00 PM ET Company Participants Sunil Bhonsle - President and CEO Marc Rubin - Executive Chairman Kate DeVarney - Executive Vice President and Chief Scientific Officer Brian Crowley - Vice President of Finance Joe Schrei - Executive Director of Commercial Operations Mike Fritz - National Sales Director Jennifer Kiernan - IR Conference Call Participants John Vandermosten - Zacks Operator Thank you for holding and welco ...

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) Q1 2020 Results Conference Call May 15, 2020 12:00 PM ET Company Participants Sunil Bhonsle - President and CEO Dr. Marc Rubin - Executive Chairman Dr. Kate DeVarney - EVP and Chief Scientific Officer Brian Crowley - VP, Finance Jennifer Kiernan - Executive Assistant to CEO and Investor Communications Conference Call Participants John Vandermosten - Zacks Operator Good day, everybody, and thank you for holding. Welcome to the Titan Pharmaceuticals First Quarter 2020 ...

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) Q4 2019 Results Conference Call March 30, 2020 4:30 PM ET Company Participants Sunil Bhonsle - President and CEO Marc Rubin - Executive Chairman Kate DeVarney - EVP and Chief Scientific Officer Dane Hallberg - EVP and Chief Commercial Officer Brian Crowley - VP, Finance and Administration Jennifer Kiernan - Executive Assistant to CEO and Investor Communications Coordinator Conference Call Participants Anita Dushyanth - Zacks Investment Research Operator Thank you fo ...

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) Q3 2019 Earnings Conference Call November 14, 2019 4:30 PM ET Company Participants Sunil Bhonsle - President and Chief Executive Officer Jennifer Kiernan - Executive Assistant to Chief Executive Officer and Investor Communications Coordinator Marc Rubin - Executive Chairman Dane Hallberg - Executive Vice President and Chief Commercial Officer Katherine DeVarney - Executive Vice President and Chief Scientific Officer Brian Crowley - Vice President of Finance and Admi ...

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) Q2 2019 Earnings Conference Call August 14, 2019 4:30 PM ET Company Participants Sunil Bhonsle - President & Chief Executive Officer Jennifer Kiernan - Executive Assistant to CEO & Investor Communications Coordinator Marc Rubin - Executive Chairman Dane Hallberg - Executive Vice President & Chief Commercial Officer Brian Crowley - Vice President-Finance Conference Call Participants Jason McCarthy - Maxim Group Ben Haynor - Alliance Global Partners John Vandermosten ...

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) Q1 2019 Results Earnings Conference Call May 15, 2019 4:30 PM ET Company Participants Sunil Bhonsle - President and CEO Marc Rubin - Executive Chairman Kate DeVarney - EVP and Chief Scientific Officer Dane Hallberg - EVP and Chief Commercial Officer Brian Crowley - VP, Finance Jennifer Kiernan - IR Conference Call Participants Ben Haynor - Alliance Global Partners Anita Dushyanth - Zacks Small-Cap Research Deepankar Roy - Brookline Capital Markets. Operator Thank yo ...

Start Time: 08:30 January 1, 0000 9:13 AM ET Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) Q4 2018 Earnings Conference Call April 02, 2019, 08:30 AM ET Company Participants Sunil Bhonsle - President and CEO Marc Rubin - Executive Chairman Kate DeVarney - EVP and Chief Scientific Officer Dane Hallberg - EVP and Chief Commercial Officer Brian Crowley - VP, Finance Jennifer Kiernan - IR Conference Call Participants Ben Haynor - Alliance Global Partners John Vandermosten - Zacks SCR Jason McCarthy - Maxim Group Ope ...